Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Plasma lipid profiling for the prognosis of 90-day mortality, in-hospital mortality, ICU admission, and severity in bacterial community-acquired pneumonia (CAP)

Fig. 2

OPLS-DA analysis of DI-MS/MS day 1 plasma metabolites comparing non-survivors (n = 75) to survivors (n = 75) of bacterial CAP patients. This shows a predictable model with a high statistical significance using VIP > 1.0 including 20 metabolites (R2Y = 0.331, Q2Y = 0.299, p = 1.15 × 10−8)

Back to article page